AKT1 and colorectal carcinoma: IGF-1R knockdown via siRNA could lead to upregulation of miR-497 and activation of PI3K/AKT signaling pathway, which in turn promoting the sensitivity of CRC cells to the chemotherapeutic drugs 5-fluorouracil and cisplatin.